On the interaction of a lipophilic drug with different sites of rat-liver microsomes. Equilibrium studies with a substituted pleuromutilin.
The binding of the diterpenoid drug 14-deoxy-14-[(2'-diethylamino-ethyl)-mercaptoacetoxy]-dihydromutilin hydrogen fumarate in the cell of rat liver is mainly to the microsomal fraction. Besides specific binding to cytochrome P-450, where the enzymic degradation of the drug occurs, we observed a very high number of identical sites (site A) with an affinity of approximately 4.2 x 10(3) M(-1) (25 degrees C, PH 7.4). Model investigations demonstrate that these interactions occur almost exclusively with the microsomal phospholipid moiety. Their capacity for the drug was determinated to be of the order of 0.2 mol/mol phospholipid. The specific interaction of the pleuromutilin derivative with cytochrome P-450 gives rise to different spectral changes of the protein. At low concentrations where weak cooperativity of the overall binding to microsomes (sites B) was found, the formation of a type I complex was observed. At increasing concentrations of the drug this interaction vanishes and a spectral change of a different type (modified type II) arises. The affinity for this complex is identical with that of the phospholipid binding sites. The interaction of the drug with the phospholipid moiety might give rise to dual effects. Firstly the very near neighbourhood of a multitude of relatively weak binding sites will facilitate a transport of the drug along the microsomal membranes. Secondly, the loading of the membranes with the drug at high concentrations might influence the binding to cytochrome P-450 so that a qualitatively different interaction takes place.